|
A more recent version of this article appeared on April 30, 2004
Papers In Press, published online ahead of print February 24, 2004
J. Biol. Chem, 10.1074/jbc.M312795200
Submitted on November 24, 2003
Revised on February 18, 2004
Accepted on February 24, 2004
Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis
Diane C. Lagace and Mark W. Nachtigal
Pharmacology, Dalhousie University, Halifax, NS B3H 1X5
Corresponding Author: Mark.Nachtigal{at}Dal.Ca
Adipogenesis is dependent on the sequential activation of transcription factors including the CCAAT/enhancer binding proteins (C/EBP), peroxisome proliferator-activated receptor gamma (PPAR ), and steroid regulatory element binding protein (SREBP). We show that the mood stabilizing drug valproic acid (VPA; 0.5-2 mM) inhibits mouse 3T3 L1 and human preadipocyte differentiation, likely through its histone deacetylase (HDAC) inhibitory properties. The HDAC inhibitor trichostatin A (TSA) also inhibited adipogenesis, whereas the VPA analog valpromide (VPM), which does not possess HDAC inhibitory effects, did not prevent adipogenesis. Acute or chronic VPA treatment inhibited differentiation yet did not affect mitotic clonal expansion. VPA (1 mM) inhibited PPAR induced differentiation, but does not activate a PPAR reporter gene, suggesting it is not a PPAR ligand. VPA or TSA treatment reduced mRNA and protein levels of PPAR , SREBP1a. TSA reduced C/EBP mRNA and protein levels, whereas VPA only produced a decrease in C/EBP protein expression. Overall our results highlight a role for HDAC activity in adipogenesis that can be blocked by treatment with VPA.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Hisahara, S. Chiba, H. Matsumoto, M. Tanno, H. Yagi, S. Shimohama, M. Sato, and Y. Horio
From the Cover: Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation
PNAS,
October 7, 2008;
105(40):
15599 - 15604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Musri, H. Corominola, R. Casamitjana, R. Gomis, and M. Parrizas
Histone H3 Lysine 4 Dimethylation Signals the Transcriptional Competence of the Adiponectin Promoter in Preadipocytes
J. Biol. Chem.,
June 23, 2006;
281(25):
17180 - 17188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Qiao, J. Schaack, and J. Shao
Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid
Endocrinology,
February 1, 2006;
147(2):
865 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kawamura, K. Ono, T. Morimoto, H. Wada, M. Hirai, K. Hidaka, T. Morisaki, T. Heike, T. Nakahata, T. Kita, et al.
Acetylation of GATA-4 Is Involved in the Differentiation of Embryonic Stem Cells into Cardiac Myocytes
J. Biol. Chem.,
May 20, 2005;
280(20):
19682 - 19688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T.-P. Yao, and R. G. Pestell
Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor {gamma}-mediated Adipogenesis through Histone Deacetylase Recruitment
J. Biol. Chem.,
April 29, 2005;
280(17):
16934 - 16941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Celis, J. M. A. Moreira, T. Cabezon, P. Gromov, E. Friis, F. Rank, and I. Gromova
Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients: Toward Dissecting The Molecular Circuitry of Epithelial-Adipocyte Stromal Cell Interactions
Mol. Cell. Proteomics,
April 1, 2005;
4(4):
492 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Lagace, R. S. McLeod, and M. W. Nachtigal
Valproic Acid Inhibits Leptin Secretion and Reduces Leptin Messenger Ribonucleic Acid Levels in Adipocytes
Endocrinology,
December 1, 2004;
145(12):
5493 - 5503.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|